Women's Health and Sexually Transmitted Infections
Sinochips Diagnostics Women’s Health and STI portfolio provides accurate, reliable results–enabling clinicians and labs to elevate patient care in reproductive health.
BD MAX™ Vaginal Panel
Real-Time Polymerase Chain Reaction (RT-PCR)
The BD MAX™ Vaginal Panel performed on the BD MAX System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from bacteria associated with bacterial vaginosis (qualitative results reported based on detection and quantitation of targeted organism markers), Candida species associated with vulvovaginal candidiasis, and Trichomonas vaginalis from vaginal swabs in patients who are symptomatic for vaginitis/vaginosis. The test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from:
- Bacterial vaginosis markers（Individual markers not reported)
- Lactobacillus spp. (L. crispatus and L. jensenii)
- Gardnerella vaginalis
- Atopobium vaginae
- Bacterial Vaginosis Associated Bacteria-2 (BVAB-2)
- Megasphaera-1
- Candida (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis)
- Candida glabrata
- Candida krusei
- Trichomonas vaginalis
BD MAX™ CT/GC/TV Panel
Real-Time Polymerase Chain Reaction (RT-PCR)
The BD MAX™ CT/GC/TV assay, as performed using the BD MAX System, incorporates automated DNA extraction and real-time polymerase chain reaction (PCR) for the direct, qualitative detection of DNA from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC) and/or Trichomonas vaginalis (TV). The assay may be used for detection of CT and/or GC DNA in male urine specimens, and the detection of CT, GC and/or TV DNA in female urine specimens, clinician-collected female endocervical swab specimens and patient-collected vaginal swab specimens (in a clinical setting). The assay is indicated for use to aid in the diagnosis of chlamydial urogenital disease, gonococcal urogenital disease and/or trichomoniasis in asymptomatic and symptomatic individuals.
Service Highlights
- FDA-cleared IVD assays
- Results available 3 days after sample receipt at Sinochips Diagnostics Laboratory
- Results directly to ordering HCP using automated LIMS
HSV-1, HSV-2, VZV, CMV Panel
Real-Time Polymerase Chain Reaction (RT-PCR)
The HSV-1, HSV-2, VZV, CMV assay performed on the BD MAX™ System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-2), varicella-zoster virus (VZV), and cytomegalovirus (CMV). The test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from:
- • Herpes simplex virus 1 (US4/gG gene)
- • Herpes simplex virus 2 (US6/gD gene)
- • Varicella-zoster virus (ORF71 gene)
- • Cytomegalovirus (DNA polymerase gene)
- • Sample Processing Control (SPC) (Drosophila DNA)
This assay is intended to aid in the diagnosis of individuals with a clinical presentation consistent with HSV-1, HSV-2, VZV, and/or CMV.
Service Highlights
- Laboratory developed IVD tests
- Results available 3 days after sample receipt at Sinochips Diagnostics Laboratory
- Results directly to ordering HCP using automated LIMS
Sinochips STI Panel
Real-Time Polymerase Chain Reaction (RT-PCR)
- The Sexually Transmitted Infections (STI) Panel is a comprehensive laboratory-developed test designed for the semi-quantitative detection of a wide array of pathogens commonly responsible for sexually transmitted infections. This panel is intended for use as a diagnostic aid in the identification and management of sexual health concerns. It assists in the detection of the following pathogens:
- • Chlamydia trachomatis
- • Neisseria gonorrhoeae
- • Mycoplasma genitalium
- • Treponema pallidum
- • Trichomonas vaginalis
- • Ureaplasma urealyticum
- • Haemophilus ducreyi
- • Human Herpes simplex virus-1
- • Human Herpes simplex virus-2
- • Human papillomavirus 16
- • Human papillomavirus 18
- • Human papillomavirus 45
- This assay is intended to aid in the diagnosis of individuals with a clinical presentation consistent with sexually transmitted infections.
Sinochips Vaginitis Panel
Real-Time Polymerase Chain Reaction (RT-PCR)
The Vaginitis (VAG) Panel is a comprehensive laboratory-developed test designed for the semi-quantitative detection of a wide array of pathogens commonly responsible for vaginal infections. It assists in the detection of the following targets:
- Bacteria
- • Gram-positive Bacteria:
- o Streptococcus agalactiae (Group B Streptococcus)
- o Enterococcus spp.
- o Staphylococcus aureus (with mecA gene)
- o Lactobacillus spp. (Jensenii, Crispatus, Gasseri, Iners)
- • Gram-negative Bacteria:
- o Gardnerella vaginalis
- o Escherichia coli
- o Prevotella bivia
- o Bacteroides fragilis
- o Mobiluncus spp. (Curtisii, Mulieris)
- o Mycoplasma hominis and Ureaplasma urealyticum
- o Atopobium vaginae
- o Megasphaera (Type 1 and Type 2)
- Fungi
- • Candida spp.:
- o Candida albicans
- o Candida glabrata
- o Candida tropicalis
- o Candida kruseii
- o Candida lusitaniae
- o Candida parapsilosis
- o Candida dubliniensis
- Parasites
- • Trichomonas vaginalis
Sinochips Human Papillomavirus (HPV) Genotyping Test
Real-Time Polymerase Chain Reaction (RT-PCR)
- The Human Papillomavirus (HPV) Genotyping Test is a comprehensive molecular diagnostic tool designed for the qualitative detection and genotyping of specific HPV types associated with cervical cancer and other HPV-related diseases. This test is intended for use in clinical laboratories to aid in the screening and management of HPV infections.
The HPV Genotyping Test targets the following HPV types:
• HPV16
• HPV18
• HPV45
• HPV31
• HPV33
• HPV51
• HPV39
• HPV35
• HPV52
• HPV68
• HPV59
• HPV56
• HPV66
• HPV58
Partnering with Sinochips Diagnostics Is Easy
Partnering with Sinochips Diagnostics Is Easy
1. Contact us
Contact Sinochips Diagnostics (877) 746-6244. Within 1 business day an account will be created, and you will receive access to our result portal.
2. Receive sample collection kits
Within 1-2 days the healthcare provider (HCP) will receive the sample collection kit for the test.
3. Send samples to us
After the test is ordered by the HCP and patient sample is collected, the HCP will put the sample, and the test order/requisition form in the provided bag and deliver to Sinochips Diagnostics.
4. Receive results
The HCP will receive the results through our result portal within 72 hours.
